SCHEMBL2123304

SCHEMBL2123304

CCCCCCCCCCCCCCCCc1ccc(N=S(=O)=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.52
▸ ADRA2A P08913 2/20 0.52
▸ ADORA3 P0DMS8 2/20 0.52
▸ TACR2 P21452 2/20 0.52
▸ SLC6A2 P23975 2/20 0.52
▸ SLC6A4 P31645 2/20 0.52
▸ SLC6A3 Q01959 2/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ SHBG P04278 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ HSPD1 P10809 1/20 0.52
▸ ADRB3 P13945 1/20 0.52
▸ HTR2C P28335 1/20 0.52
▸ HSPE1 P61604 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ TST Q16762 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8509668 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL8104099 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL20420630 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL20420627 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL8109973 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL2167421 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL2237323 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL20420629 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL8106468 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL8104097 0.79 ESR1 (0.61) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2658928-B1 SURFACE-MODIFIED PIGMENT PREPARATIONS BASF SE (DE) 2019-03-27 — — EP disclosed
US-9346963-B2 Surface-modified pigment preparations BASF SE (DE) 2016-05-24 — — US disclosed
US-8753550-B2 Surface-modified pigment compositions BASF SE (DE) 2014-06-17 — — US disclosed
EP-2658928-A1 SURFACE-MODIFIED PIGMENT PREPARATIONS BASF SE (DE) 2013-11-06 — — EP disclosed
US-20130289174-A1 SURFACE-MODIFIED PIGMENT PREPARATIONS BASF SE (DE) 2013-10-31 — — US disclosed
EP-2443201-B1 SURFACE-MODIFIED PIGMENT COMPOSITIONS BASF SE (DE) 2013-08-14 — — EP disclosed
WO-2012089516-A1 SURFACE-MODIFIED PIGMENT PREPARATIONS BASF SE (DE) 2012-07-05 — — WO disclosed
US-20120126184-A1 SURFACE-MODIFIED PIGMENT COMPOSITIONS BASF SE (DE) 2012-05-24 — — US disclosed
EP-2443201-A2 SURFACE-MODIFIED PIGMENT COMPOSITIONS BASF SE (DE) 2012-04-25 — — EP disclosed
WO-2010146034-A2 SURFACE-MODIFIED PIGMENT COMPOSITIONS BASF SE (DE) 2010-12-23 — — WO disclosed
US-6896726-B2 Surface-treated organic pigments CIBA SPECIALTY CHEMICALS CORP. (US) 2005-05-24 — — US disclosed
US-20040138340-A1 Surface-treated organic pigments CIBA SPECIALTY CHEMICALS CORP. 2004-07-15 — — US disclosed
EP-1387868-A1 SURFACE-TREATED ORGANIC PIGMENTS Ciba SC Holding AG (CH) 2004-02-11 — — EP disclosed
WO-2002094944-A1 SURFACE-TREATED ORGANIC PIGMENTS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-11-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120126184-A1 SURFACE-MODIFIED PIGMENT COMPOSITIONS NR2E3, CRY1, CHRNA7 ESR1 518/4885ADRA2A 2041/4885ADORA3 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback